Study finds infection, other complications more likely for patients with difficult lives
by rjcrossley on Sat Nov 24, 2012 09:24 PM
I support Dr Burzynski he has save so Manny terminal ill brain cancer patients its not funny. Yet though he had not broken any FDA codes, and he has pass one hearing all ready The boards is still trying to get him deregistered how do you feel about this http://www.youtube.com/watch?v=hCrsn8ziGWU&feature=share
by gbmdoug on Sat Nov 24, 2012 11:26 PM
There's a reason there are so many who believe this guy is a predatory quack; he doesn't play by the rules and his urine treatments send many to the poor house and are not based on any rational science (which is why the FDA is coming down on him).
by jpearson472 on Sun Nov 25, 2012 01:00 AM
until these quackjobs allow full fda studies to either prove or disprove there stuff, they shouold all be banned.
by Idyllwild on Sun Nov 25, 2012 02:17 AM
I hope he will lose his practice so that he cannot prey on cancer patients any longer. He has had many opportunities to prove his treatments work, but he never has proven them. Evidence is real, Burzynski is a quack.
by siblingof on Sun Nov 25, 2012 02:51 PM
by Cando on Mon Nov 26, 2012 12:14 AM
I feel wonderful. The man is a quack, and should have his liscence taken away. He steals from those without hope. Evil.
When you track a discussion, you will get notified by e-mail if anyone else posts a new message on this discussion. Are you sure you want to track this discussion?
If you stop tracking this discussion, you will no longer get notified by e-mail if anyone else posts a new message on this discussion. Are you sure you want to stop tracking this discussion?
If you were considering traveling for cancer treatment, which headline would you find more interesting?
Destination: HOPE. Cancer care that is worth the trip.
Over 84% of our patients travel to our hospital from another state
Neither headline is interesting
We care about your feedback. Let us know how we can improve your CancerCompass experience.